Search for: "Eli, Inc." Results 281 - 300 of 1,001
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Mar 2013, 10:11 am by Lawrence B. Ebert
See In re Eli Lilly, 902 F.2d 943 (Fed. [read post]
10 Sep 2012, 1:17 am by Sam Antar
I no financial relationship with United Realty Trust Inc. or any of its affiliates. [read post]
11 Oct 2018, 12:57 am by Eszter Szakács
Eszter SzakácsCo-author: Zsolt Lengyel, Danubia Patent and Law Office Just a few months before the CJEU’s judgment in C-121/17 Teva UK Ltd and Others v Gilead Sciences Inc. came out a the Metropolitan Court of Budapest handed down a decision regarding Merck Sharp and Dohme Corp’s (MSD) application for an SPC re the combination of ezetimibe and rosuvastatin. [read post]
13 Jul 2022, 2:52 pm by Unknown
Federal Courts Bulletinhttps://www.narf.org/nill/bulletins/federal/2022.html Bird Industries, Inc v. [read post]
13 Dec 2023, 12:11 pm by Unknown
(Grazing Land Leasing; Administrative Procedures Act) Eagle Bear, Inc. v. [read post]
7 Dec 2018, 2:23 pm by Lawrence B. Ebert
TevaParenteral Meds., Inc., 689 F.3d 1368, 1376 (Fed. [read post]
7 Aug 2023, 6:01 am by Levin Papantonio
Martinotti, who presides over the three most advanced actions related to the alleged insulin pricing scheme.The newly formed Insulin Price-Fixing MDL (No. 3080) will serve to "avoid duplication of discovery, prevent inconsistent pretrial rulings, and to conserve the resources of the parties, their counsel and the judiciary," the panel explains on its website.Defendants in these actions include insulin manufacturers Eli Lilly and Company, Novo Nordisk, Inc., and… [read post]
7 Dec 2023, 6:00 am by Levin Papantonio
The JPML issued a Transfer Order to centralize lawsuits alleging that drug manufacturers and pharmacy benefit manufacturers (PBMs) engaged in an unfair and deceptive conspiracy to orchestrate an insulin pricing scheme.Defendants in these actions include insulin manufacturers Eli Lilly and Company, Novo Nordisk, Inc., and Sanofi-Aventis U.S. [read post]
23 Sep 2013, 10:00 am by Florian Mueller
But there comes a point where there are so many obstacles to enforcement that innovators are concerned.The Innovation Alliance is one of more than 100 signatories to a letter that is addressed to the chairmen and ranking members of the Senate and House Judicairy Commitees and raises two primary concerns: it considers the expanded CBM proposals to result in "discriminati[on] against an entire class of technology innovation", which would run counter to U.S. efforts to convince other countries of the… [read post]